These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2848432)
21. A short report on highlights of world-wide development of RIX4414: an European experience. Vesikari T; Karvonen A; Puustinen L; Szakal ED; Zeng SQ; Delem A; De Vos B Vaccine; 2006 May; 24(18):3779. PubMed ID: 16581159 [No Abstract] [Full Text] [Related]
22. Clinical and immunological studies of rotavirus vaccines. Vesikari T Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185 [TBL] [Abstract][Full Text] [Related]
24. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Treanor JJ; Clark HF; Pichichero M; Christy C; Gouvea V; Shrager D; Palazzo S; Offit P Pediatr Infect Dis J; 1995 Apr; 14(4):301-7. PubMed ID: 7603812 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329 [TBL] [Abstract][Full Text] [Related]
27. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. Bhandari N; Sharma P; Taneja S; Kumar T; Rongsen-Chandola T; Appaiahgari MB; Mishra A; Singh S; Vrati S; J Infect Dis; 2009 Aug; 200(3):421-9. PubMed ID: 19545211 [TBL] [Abstract][Full Text] [Related]
28. Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life. Kawamura N; Tokoeda Y; Oshima M; Okahata H; Tsutsumi H; Van Doorn LJ; Muto H; Smolenov I; Suryakiran PV; Han HH Vaccine; 2011 Aug; 29(37):6335-41. PubMed ID: 21640780 [TBL] [Abstract][Full Text] [Related]
29. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Boom JA; Tate JE; Sahni LC; Rench MA; Quaye O; Mijatovic-Rustempasic S; Patel MM; Baker CJ; Parashar UD Pediatr Infect Dis J; 2010 Dec; 29(12):1133-5. PubMed ID: 20634776 [TBL] [Abstract][Full Text] [Related]
30. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Vesikari T; Ruuska T; Delem A; André FE Pediatr Infect Dis J; 1987 Feb; 6(2):164-9. PubMed ID: 3031574 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. Perez-Schael I; Salinas B; Tomat M; Linhares AC; Guerrero ML; Ruiz-Palacios GM; Bouckenooghe A; Yarzabal JP J Infect Dis; 2007 Aug; 196(4):537-40. PubMed ID: 17624838 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084 [TBL] [Abstract][Full Text] [Related]
33. A trial of RIT-4237 rotavirus vaccine in 1-month-old infants. Mutz ID; Krainer F; Deutsch J; Kunz C; Teuwen DE Eur J Pediatr; 1989 Jun; 148(7):634-5. PubMed ID: 2545451 [TBL] [Abstract][Full Text] [Related]
34. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group. Ward RL; Bernstein DI Vaccine; 1995 Sep; 13(13):1226-32. PubMed ID: 8578808 [TBL] [Abstract][Full Text] [Related]